Retinoblastoma Phase II Expanded Access Clinical Trial
Retinoblastoma Phase II Expanded Access Clinical Trial
Recruiting · NCT06679634 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Retinoblastoma Phase II Expanded Access Clinical Trial | Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, eye disorder, neoplasm, neuroepithelial neoplasm, ocular cancer, primitive neuroectodermal tumor, retinal cancer, retinal disorder, retinoblastoma | Recruiting | Phase 2 | 2026-05-22 | NCT06679634 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Morgan Stanley Children's Hospital | 4 |
| Targeted Therapy Technologies, LLC | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Wisconsin | Milwaukee | United States | 23 |
| NewYork Presbyterian Morgan Stanley Children's Hospital | New York | United States | 2 |